A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
Public ClinicalTrials.gov record NCT04109950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Extension Study to Assess the Safety and Tolerability of SEP-363856 in Subjects With Schizophrenia
Study identification
- NCT ID
- NCT04109950
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 463 participants
Conditions and interventions
Conditions
Interventions
- SEP-363856 Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 19, 2019
- Primary completion
- Nov 8, 2023
- Completion
- Nov 8, 2023
- Last update posted
- Dec 15, 2024
2019 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Little Rock | Arkansas | 72211 | — |
| Research Site | Rogers | Arkansas | 72758 | — |
| Research Site | Anaheim | California | 92805 | — |
| Research Site | Culver City | California | 90230 | — |
| Research Site | Lemon Grove | California | 91945 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Long Beach | California | 90807 | — |
| Research Site | Montclair | California | 91763 | — |
| Research Site | San Diego | California | 92102 | — |
| Research Site | Sherman Oaks | California | 91403 | — |
| Research Site | Miami Springs | Florida | 33166 | — |
| Research Site | Oakland Park | Florida | 33334 | — |
| Research Site | Atlanta | Georgia | 30030 | — |
| Research Site | Atlanta | Georgia | 30318 | — |
| Research Site | Atlanta | Georgia | 30331 | — |
| Research Site | Decatur | Georgia | 30030 | — |
| Research Site | Lake Charles | Louisiana | 70629 | — |
| Research Site | Gaithersburg | Maryland | 20877 | — |
| Research Site | Flowood | Mississippi | 39232 | — |
| Research Site | St Louis | Missouri | 63125 | — |
| Research Site | Marlton | New Jersey | 08053 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | Dayton | Ohio | 45417 | — |
| Research Site | Austin | Texas | 78754 | — |
| Research Site | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04109950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 15, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04109950 live on ClinicalTrials.gov.